Advertisement
UK markets close in 1 hour 11 minutes
  • FTSE 100

    8,212.17
    -13.16 (-0.16%)
     
  • FTSE 250

    20,349.90
    +51.80 (+0.26%)
     
  • AIM

    764.44
    -1.48 (-0.19%)
     
  • GBP/EUR

    1.1810
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2657
    +0.0034 (+0.27%)
     
  • Bitcoin GBP

    49,169.48
    +234.55 (+0.48%)
     
  • CMC Crypto 200

    1,292.85
    +26.71 (+2.11%)
     
  • S&P 500

    5,485.38
    +7.48 (+0.14%)
     
  • DOW

    39,166.72
    +38.92 (+0.10%)
     
  • CRUDE OIL

    81.60
    +0.70 (+0.87%)
     
  • GOLD FUTURES

    2,337.50
    +24.30 (+1.05%)
     
  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     
  • HANG SENG

    17,716.47
    -373.46 (-2.06%)
     
  • DAX

    18,230.71
    +75.47 (+0.42%)
     
  • CAC 40

    7,569.11
    -40.04 (-0.53%)
     

Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.

Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.

There were zero HIV cases among the 2,124 test subjects who received the antiviral injection called lenacapavir.